What is Tirzepatide?
Tirzepatide is a synthetic peptide composed of 39 amino acids. It is a dual agonist of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This combined activity distinguishes it from other incretin analogues that act only on the GLP-1 receptor.
Initially developed for the treatment of type 2 diabetes mellitus, clinical trials have shown a pronounced effect on body weight reduction. In research models, improved insulin sensitivity, blood sugar control, and a positive impact on metabolic and cardiovascular parameters have been observed.
Observations on Tirzepatide
Tirzepatide is being studied for its possible effects on:
Blood sugar control – in research models, a decrease in HbA1c and glucose peaks has been observed.
Weight reduction – an effect on body fat loss and improvement in body composition has been reported.
Metabolic health – an improvement in lipid profile and reduction of hepatic steatosis has been observed.
Cardiovascular function – in research settings, a decrease in blood pressure and triglycerides has been reported.
Energy homeostasis – an effect related to increased fat oxidation and optimization of energy balance has been observed.
Scientific Data
Tirzepatide has been studied in large clinical trials, where it emerges as a potent incretin analogue with a wide range of benefits.
In patients with type 2 diabetes mellitus, the following have been reported:
- HbA1c reduction by up to 2%
- Weight loss of 10-15%
- Improvement in lipid profile and blood pressure
In people with obesity without diabetes, the following have been observed:
- Weight loss of up to 20% in 72 weeks
- Reduction of visceral fat
- Improvement in cardiometabolic parameters
Administration and Dosage
Subcutaneous administration once a week has been described in scientific literature.
Standard doses: 2.5 mg - initial dose with gradual titration up to 5 mg weekly depending on tolerance and therapeutic effect.
For 5 mg + 2 ml bacteriostatic water:
Concentration = 2.5 mg/ml → 0.4 ml = 1 mg
Example values for 5 mg:
0.1 ml = 250μg
0.2 ml = 500μg
0.3 ml = 750μg
0.4 ml = 1 mg
0.5 ml = 1.25 mg
For 10 mg + 2 ml bacteriostatic water:
Concentration = 5 mg/ml → 0.2 ml = 1 mg
Example values for 10 mg:
0.1 ml = 500μg
0.2 ml = 1 mg
0.3 ml = 1.5 mg
0.4 ml = 2 mg
0.5 ml = 2.5 mg
Possible Side Effects
The most commonly reported reactions are related to the gastrointestinal tract.
Possible side effects are highly dose-dependent and include:
- nausea, vomiting, diarrhea, constipation
- decreased appetite
- abdominal discomfort
Rarer but more serious risks include:
- pancreatitis
- cholelithiasis with rapid weight reduction
- hypoglycemia when combined with other antidiabetic agents
The information is gathered and systematized from various scientific sources and studies. It serves solely for educational purposes and should not be used for diagnosis, treatment, or prevention of diseases.